2016
DOI: 10.1016/j.jclinane.2015.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Tramadol wound infiltration is not different from intravenous tramadol in children: a randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Implementation of bupivacaine infused collagen-matrix implant resulted in improved postoperative analgesia and lower opioid use for up to 72 h compared to placebo [150]. Single-shot WI before skin closure with tramadol (1 mg/kg) reduced pain scores and analgesic use compared to WI with bupivacaine, but this difference could be attributed to systemic resorption of tramadol [49,151]. WI with meloxicam (7.5 mg) offered no efficacy advantage over systemic administration, but could potentially elicit fewer systemic adverse events [50].…”
Section: Inguinal Herniorrhaphymentioning
confidence: 99%
“…Implementation of bupivacaine infused collagen-matrix implant resulted in improved postoperative analgesia and lower opioid use for up to 72 h compared to placebo [150]. Single-shot WI before skin closure with tramadol (1 mg/kg) reduced pain scores and analgesic use compared to WI with bupivacaine, but this difference could be attributed to systemic resorption of tramadol [49,151]. WI with meloxicam (7.5 mg) offered no efficacy advantage over systemic administration, but could potentially elicit fewer systemic adverse events [50].…”
Section: Inguinal Herniorrhaphymentioning
confidence: 99%